background
latest
outbreak
infecti
diseas
caus
huge
medic
challeng
china
entir
globe
unifi
diagnost
standard
formul
initi
diagnosi
remain
base
posit
nucleic
acid
test
howev
earli
nucleic
acid
test
identifi
neg
patient
wherea
patient
exhibit
characterist
ct
chang
lung
posit
test
result
appear
repeat
nucleic
acid
test
caus
failur
diagnos
patient
earli
studi
aim
delv
relationship
initi
nucleic
acid
test
earli
lung
ct
chang
patient
method
accord
latest
diagnost
criteria
patient
diagnos
treat
infect
v
ward
xiaogan
central
hospit
retrospect
analyz
consist
first
nucleic
acid
test
posit
lung
ct
chang
studi
addit
sensit
specif
ct
initi
nucleic
acid
studi
result
kappa
coeffici
initi
nucleic
acid
posit
chang
lung
ct
chang
posit
nucleic
acid
test
gold
standard
sensit
lung
ct
ci
chang
ct
gold
standard
sensit
nucleic
acid
posit
ci
conclus
consist
initi
posit
nucleic
acid
test
ct
chang
lung
poor
low
sensit
achiev
initi
nucleic
acid
detect
ct
chang
use
softwar
packag
kappa
coeffici
adopt
measur
consist
nucleic
acid
chang
lung
ct
initi
kappa
posit
nucleic
acid
chang
lung
ct
chang
reach
tabl
base
gold
standard
latest
outbreak
infecti
diseas
impos
great
damag
china
countri
worldwid
present
univers
recogn
gold
standard
initi
diagnosi
initi
diagnosi
still
reli
nucleic
acid
test
initi
nucleic
acid
test
neg
wherea
time
characterist
lung
chang
appear
repeat
nucleic
acid
test
posit
result
consider
number
earli
patient
miss
studi
relationship
nucleic
acid
test
ct
chang
lung
help
improv
diagnosi
patient
diagnos
admit
infecti
v
ward
xiaogan
central
hospit
retrospect
analyz
includ
male
femal
maximum
age
year
minimum
age
year
histori
lung
infect
onset
throat
swab
collect
patient
nucleic
acid
gene
n
gene
taken
target
gene
rtpcr
adopt
detect
posit
nucleic
acidposit
indic
initi
nucleic
acid
test
neg
test
repeat
least
day
test
posit
base
chang
sheetshap
frost
glassflocculationstrandlik
chang
outer
band
lung
lung
ct
posit
indic
fig
studi
consist
ct
chang
posit
initi
nucleic
acid
test
time
sensit
specif
ct
chang
studi
posit
nucleic
acid
test
gold
standard
sensit
specif
initi
nucleic
acid
posit
studi
ct
lung
gold
standard
nucleic
acid
pcr
test
sensit
lung
ct
ci
specif
tabl
lung
ct
chang
gold
standard
nucleic
acid
pcrposit
sensit
ci
specif
ci
tabl
exact
consist
initi
posit
nucleic
acid
test
ct
chang
lung
employ
posit
nucleic
acid
test
gold
standard
initi
diagnosi
sensit
ct
chang
lung
low
use
ct
chang
lung
gold
standard
sensit
posit
nucleic
acid
test
low
well
initi
nucleic
acid
test
act
diagnost
indic
numer
confirm
patient
miss
initi
diagnosi
perform
combin
nucleic
acid
test
ct
chang
lung
latest
outbreak
infecti
diseas
unifi
diagnost
standard
diagnosi
latest
chines
standard
split
suspect
case
confirm
case
diagnosi
suspect
case
combin
epidemiolog
histori
clinic
manifest
epidemiolog
histori
includ
histori
travel
resid
affect
area
histori
contact
patient
epidem
area
fever
respiratori
symptom
aggress
onset
clinic
manifest
consist
fever
respiratori
symptom
characterist
lung
imag
chang
total
number
white
blood
cell
normal
decreas
earli
stage
onset
lymphocyt
count
decreas
diagnost
criteria
suspect
case
compli
one
epidemiolog
histori
two
clinic
manifest
suspect
case
one
follow
pathogen
evid
refer
confirm
case
pcr
test
nucleic
acid
posit
respiratori
specimen
blood
specimen
respiratori
blood
specimen
viru
gene
sequenc
significantli
homolog
known
howev
numer
patient
initi
nucleic
acid
test
identifi
neg
patient
posit
repeat
test
time
nucleic
acid
posit
chang
ct
occur
lung
result
suggest
initi
nucleic
acid
posit
consist
variat
lung
ct
low
initi
nucleic
acid
posit
rate
achiev
posit
initi
nucleic
acid
act
gold
standard
sensit
characterist
lung
ct
chang
caus
huge
interfer
even
mislead
clinic
work
result
diagnosi
treatment
delay
even
potenti
patient
isol
time
therebi
caus
spread
viru
characterist
lung
ct
chang
adopt
gold
standard
sensit
initi
nucleic
acid
test
still
low
caus
situat
still
relat
low
posit
rate
initi
nucleic
acid
test
studi
consid
caus
low
sensit
initi
nucleic
acid
test
includ
method
sampl
acquisit
time
acquisit
well
reagent
use
test
advers
affect
test
result
decreas
posit
rate
studi
aim
explor
relationship
posit
initi
nucleic
acid
test
consist
lung
ct
chang
attempt
facilit
effect
screen
suspect
patient
indepth
analysi
conduct
consist
posit
nucleic
acid
chang
lung
ct
chang
repeat
nucleic
acid
test
requir
research
conclus
poor
consist
posit
rate
initi
nucleic
acid
test
chang
lung
ct
patient
initi
nucleic
acid
test
exhibit
low
sensit
studi
suggest
patient
neg
initi
nucleic
acid
test
lung
ct
chang
isol
earli
stage
repeat
nucleic
acid
test
requir
author
declar
compet
interest
fund
conflict
